The advantages of using transtelephonic ECG monitoring device in outpatients with paroxysmal form of atrial fibrillation

31 August 2025 (08:15 - 09:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Ms Manizha Hamidzoda

International Clinic Avicenna, Dushanbe (Tajikistan)

5 More presentations in this session

Presentation thumbnail

Nearly nine year follow-up data on a leadless pacing system real life experience in comparison to data of the prospective trial

Doctor S. Winter (Cologne, DE)

Abstract Slides Video

Presentation thumbnail

Omega-3 Fatty Acids reduce rate and QT-interval, but increase electrical instability in cardiomyocytes

Doctor C. Balbi (Zurich, CH)

Abstract Slides Video

Presentation thumbnail

HARBOR-AF: a multicentre, open-label, dose escalation study of the efficacy, safety, and tolerability of budiodarone for the treatment of subjects with paroxysmal atrial fibrillation

Doctor C. Flynn (San Francisco Bay, US)

Abstract Slides Video

Presentation thumbnail

Guidelines and heartlines: evaluating procainamide use at a large academic medical center

Doctor T. Ahuja (New York, US)

Abstract Slides Video

Presentation thumbnail

Trends in arrhythmia-related mortality among adults with hyperthyroidism in the U.S. from 1999 to 2020: A CDC WONDER analysis

Miss O. Dairo (London, GB)

Abstract Slides Video

Access the full session

Session thumbnail

Cardiac rhythm disorders: devices, drugs, and outcomes

The Event

Event poster

ESC Congress 2025

31 August 2025 08:15 CET

You may be interested in

Congress Session

Transforming population health through mobile technology

Congress Session

Smaller trials, trial updates, and other studies on atrial fibrillation

Congress Session

Innovations in remote patient care

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources